# FDA Inspection 1016472 - American National Red Cross - June 06, 2017

Source: https://www.keypedia.com/records/fda_inspections/american-national-red-cross/981e8a25-6cb2-4b99-a13c-ca88657dcefe
Source feed: FDA_Inspections

> FDA Inspection 1016472 for American National Red Cross on June 06, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1016472
- Company Name: American National Red Cross
- Inspection Date: 2017-06-06
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1253097 - 2024-10-29](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/0a2dad9f-cc04-4eff-841f-a2a4bbb514fd)
- [FDA Inspection 1253097 - 2024-10-29](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/f507e403-5580-4658-95b2-5783f970b957)
- [FDA Inspection 1097486 - 2019-06-25](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/37b5db52-2fb0-4888-a779-88ff1fae80e1)
- [FDA Inspection 906510 - 2014-12-02](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/95a660b1-2407-4039-8632-8de6275e51d6)
- [FDA Inspection 832369 - 2013-05-21](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/bebcfcfa-57a4-46fc-be32-2b3cdbff19c1)

Company: https://www.keypedia.com/companies/american-national-red-cross/348f3f43-97e5-4202-b418-aa25e17cf50e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d